Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of I Ks-encoding genes and potential implications in regional heterogeneity of their expressions

Journal of Cellular Physiology

Volumn 212, Issue 2, 2007, Pages 358-367

  Luo, Xiaobin ^a,b,c   Xiao, Jiening ^a,c   Lin, Huixian ^a,c   Li, Baoxin ^c   Lu, Yanjie ^c   Yang, Baofeng ^c   Wang, Zhiguo ^a,b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; INWARDLY RECTIFYING POTASSIUM CHANNEL; MICRORNA; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; SYNAPSIN I; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL LINE; GENE EXPRESSION; GENES, REPORTER; HEART VENTRICLES; HUMANS; KCNQ1 POTASSIUM CHANNEL; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTATION; POTASSIUM CHANNELS, VOLTAGE-GATED; PROMOTER REGIONS (GENETICS); RATS; RNA INTERFERENCE; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 34347404509     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21030     Document Type: Article

References (40)

1. Akar FG, Tomaselli GF. 2005. Ion channels as novel therapeutic targets in heart failure. Ann Med 37:44-54.
2. Alvarez-Garcia I, Miska EA. 2005. MicroRNA functions in animal development and human disease. Development 132:4653-4662.
3. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
4. Ks cardiac potassium current. Nature 384:78-80.
5. Black AR, Black JD, Azizkhan-Clifford J. 2001. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143-160.
6. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ. 2004. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119:591-602.
7. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033.
8. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233.
9. Cheng AM, Byrom MW, Shelton J, Ford LP. 2005. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290-1297.
10. Courey AJ, Tjian R. 1998. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-898.
11. Day CP, McComb JM, Campbell RWF. 1990. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63:342-344.
12. Ks in electrical heterogeneity. Am J Physiol 268:H604-H613.
13. Griffiths-Jones S. 2004. The miRNA registry. Nucleic Acids Res 32:D109-D111.
14. Ks in human ventricular muscle. Circulation 112:1392-1399.
15. Kadonaga JT, Courey AJ, Ladika J, Tjian R. 1988. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242:1566-1570.
16. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689.
17. Ks contributes to the longer action potential of the M cell. Circ Res 76:351-365.
18. Lundquist AL, Turner CL, Ballester LY, George AL, Jr. 2006. Expression and transcriptional control of human KCNE genes. Genomics 87:119-128.
19. Meister G, Tuschl T. 2004. Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349.
20. v1.2 isoforms under the control of distinct 5′-flanking regulatory elements. FEBS Lett 546:349-354.
21. Pereon Y, Demolombe S, Baro I, Drouin E, Charpentier F, Escande D. 2000. Differential expression of KvLQT1 isoforms across the human ventricular wall. Am J Physiol 278:H1908-H1915.
22. Pugh BF, Tjian R. 1990. Mechanism of transcriptional activation by Sp1: Evidence for coactivators. Cell 61:1187-1197.
23. Ks in canine hypertrophied hearts. Cardiovasc Res 57:486-496.
24. Ramakers C, Stengl M, Spatjens RL, Moorman AF, Vos MA. 2005. Molecular and electrical characterization of the canine cardiac ventricular septum. J Mol Cell Cardiol 38:153-161.
25. Roden DM, Yang T. 2005. Protecting the heart against arrhythmias: Potassium current physiology and repolarization reserve. Circulation 112:1376-1378.
26. Ks potassium channel. Nature 384:80-83.
27. + current in the myogenic H9c2 cells: Biophysical property and molecular identify. Cell Physiol Biochem 12:215-226.
28. Szabo G, Szentandrassy N, Biro T, Toth BI, Czifra G, Magyar J, Banyasz T, Varro A, Kovacs L, Nanasi PP. 2005. Asymmetrical distribution of ion channels in canine and human left-ventricular wall: Epicardium versus midmyocardium. Pflugers Arch 450:307-316.
29. Szentadrassy N, Banyasz T, Biro T, Szabo G, Toth BI, Magyar J, Lazar J, Varro A, Kovacs L, Nanasi PP. 2005. Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium. Cardiovasc Res 65:851-860.
30. Tsuji Y, Opthof T, Yasui K, Inden Y, Takemura H, Niwa N, Lu Z, Lee JK, Honjo H, Kamiya K, Kodama I. 2002. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block. Circulation 106:2012-2018.
31. Tsuji Y, Zicha S, Qi XY, Kodama I, Nattel S. 2006. Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia: Discrete arrhythmogenic consequences related to differential delayed-rectifier changes. Circulation 113:345-355.
32. + fluxes in mouse proximal tubule. J Am Soc Nephrol 12:2003-2011.
33. Verduyn SC, Vos MA, van der Zande J, van der Hulst FF, Wellens HJ. 1997a. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: Reversal by magnesium. Cardiovasc Res 34:453-463.
34. Verduyn SC, Vos MA, van der Zande J, Kulcsar A, Wellens HJ. 1997b. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol 30:1575-1584.
35. Ks are larger in right than left canine ventricular midmyocardium. Circulation 99:206-210.
36. + currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100:2455-2461.
37. Wang H, Han H, Zhang L, Shi H, Schram G, Nattel S, Wang Z. 2001. Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol 59:1029-1036.
38. + channel function as a mechanism for insulin treatment of the abnormal QT prolongation and the associated arrhythmias in diabetic rabbits. Am J Physiol 291:1446-1455.
39. Zhao Y, Samal E, Srivastava D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220.
40. Zheng W, Verlander JW, Lynch IJ, Cash MN, Shao J, Stow LR, Cain BD, Weiner ID, Wall SM, Wingo CS. 2007. Cellular distribution of the potassium channel, KCNQ1, in normal mouse kidney. Am J Physiol Renal Physiol 292:F456-F466.